PRCT

NASD PROCEPT BioRobotics Corp.
Nov 19, 2026 · 9:10 AM ET LAST TRADE Market Closed

$24.71 ↓ -0.47 (-1.87%) Trading Down from the previous close of $25.18

YTD change
-21.46%
vs 20-day SMA
+14.92%
vs 200-day SMA
+8.23%

Price ranges

Previous day
$23.55 $25.84
open $23.66 close $25.18
+$1.52 (+6.42%)
Today
$0.00 $0.00
$24.71
Past week
$23.03 $25.84
from $23.34 now $24.71
+$1.37 (+5.87%)
Past month
$18.23 $25.84
from $18.27 now $24.71
+$6.44 (+35.25%)
This year
$16.67 $35.40
from $31.46 now $24.71
-$6.75 (-21.46%)

Price & Performance

-0.73 (-2.82%) / 6M

$15.70$20.49$25.29$30.08May 19Aug 19Nov 18

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 76.2% away from all-time highs of $103.81
  • PRCT is down 21% since the beginning of the year
  • PRCT is down 12% over the past 12 months
  • PRCT is up 35% over the past 1 month
  • 14% of all PRCT investors are betting against PRCT

PRCT reads neutral: price sits above both the 20- and 200-day averages, the 12-month move is -9.8%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.46
Earnings momentum -104.4% Quarterly EPS growth
Quarterly change -104.4%

Valuation

P/E ratio N/A
Enterprise value $1.3B
Beta 1.44

Balance sheet & scale

IncomeN/A
Revenue$352.3M
Cash$218.4M
Debt$77.0K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $1.4B

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. It manufactures and sells the AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating BPH. The firm's proprietary AquaBeam Robotic System employs a single-use disposable handpiece to deliver its Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. The company was founded by Nikolai Aljuri and Rodney C. Perkins in 2007 and is headquartered in San Jose, CA.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CIBC CDR C REG S $34.68 -2.14%
BDX Becton, Dickinson and Company $216.08 +0.31%
MDLN Medline, Inc. Class A $39.16 +3.93%
DXCM DexCom, Inc. $82.52 +0.59%
WST West Pharmaceutical Services, Inc. $404.02 -2.44%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.